Related Experiment Video
Updated: Jun 8, 2026

05:58
Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
Published on: March 22, 2022
Maltose interference-free test strips for blood glucose testing at point-of-care: a laboratory performance evaluation
Wai-Yoong Ng1, Chiau Chiae Tiong, Edward Jacob
1Department of Pathology, Singapore General Hospital, Outram Road, Republic of Singapore. ng.wai.yoong@sgh.com.sg
Diabetes Technology & Therapeutics
|October 1, 2010
Summary
New Accu-Chek Performa test strips offer accurate blood glucose monitoring, unaffected by maltose interference. These improved strips meet ISO standards for reliable point-of-care testing.
Area of Science:
- Biomedical Engineering
- Clinical Chemistry
Background:
- Maltose interference poses a challenge for point-of-care blood glucose testing accuracy.
- A modified recombinant glucose dehydrogenase-pyrroloquinoline quinone system was developed to address maltose interference.
Purpose of the Study:
- To evaluate the performance of a new maltose interference-free test strip for the Accu-Chek Performa glucose meter.
- To assess the impact of various sugars, including maltose, on glucose testing results.
Main Methods:
- 120 blood specimens were analyzed for imprecision, linearity, and method comparison against a clinical laboratory standard.
- Two specimens were spiked with maltose, xylose, and galactose to evaluate sugar interference across different test strips.
- Performance was assessed using Clarke Error Grid analysis and Bland-Altman plots.
Main Results:
- The modified Performa test strips demonstrated high precision (CV < 7%) and excellent correlation with laboratory results (Spearman's r² = 0.960).
- Maltose and xylose did not interfere with glucose measurements, while galactose showed some interference.
- 99% of results met ISO 15197:2003 performance criteria, indicating high accuracy.
Conclusions:
- The modified Accu-Chek Performa test strips effectively eliminate maltose and xylose interference.
- These test strips meet stringent ISO 15197:2003 standards, providing reliable glucose measurements.
- The study confirms the suitability of these improved test strips for accurate point-of-care glucose monitoring.
Related Concept Videos
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

